13 September 2011
Mike Ward
Please Login to read the full article.
RELATED CONTENT
NEWS
- Progenics to narrow focus to oncology, cut staff by 26%
- Investors look for better efficacy from safe cancer immunotherapies
- Nearly smooth sailing predicted at ODAC for Seattle Genetics' lymphoma drug
- $16.5m top-up propels Sutro's unnatural approach to biologics and drug conjugates
ANALYSIS
Other Informa Analysis
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
